Mannatech GAAP EPS of $4.61, revenue of $24.87M
Mannatech reported Q3 GAAP earnings per share of $4.61 and revenue of $24.87M, down 14.8% year-over-year, according to a press release.
MANNATECH INC
Mannatech develops and sells proprietary nutritional supplements, skin care and anti-aging products, and weight-management and fitness products for consumers seeking health and wellness products. Its sole reporting segment operates in twenty-five markets. Products are organized into Integrative Health, Targeted Health, Weight and Fitness, Skin Care, and Essentials categories. Brands and products include Ambrotose, TruHealth, Luminovation, and OsoLean. Mannatech principally sells through network marketing, with independent associates and preferred customers purchasing products; independent associates can participate in its compensation plan, while preferred customers cannot. In mainland China, its subsidiary Meitai sells Mannatech products through a cross-border e-commerce website for personal use, with a rewards program for customer referrals. Mannatech contracts with third parties to manufacture all its products. It is headquartered in Flower Mound, Texas.
No SEC Form 4 filings for $MTEX in the last 30 days.
See all $MTEX insider activity →Mannatech reported Q3 GAAP earnings per share of $4.61 and revenue of $24.87M, down 14.8% year-over-year, according to a press release.
MANNATECH INC (MTEX) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Mannatech Reports Financial Results for Third Quarter 2026 (Flower Mound, Texas) November 12, 2026 - Mannatech, Incorporated (NASDAQ: MTEX ), ("Mannatech" or "Company"), global health and wellness company committed to transforming lives to make a better world, today
Mann (MTEX) believes it has regained compliance with Nasdaq's $2.5M equity requirement after acquiring 100% ownership of its Swiss subsidiary. The Swiss tax authority ruled distributions now qualify for a reduced 5% withholding rate, altering deferred tax liabilities. Nasdaq will continue monitoring. According to the company, the changes were effective as of September 30, 2026.
Over the past 7 days, AlphAI's AI scored 2 news stories mentioning MTEX (MANNATECH INC). Coverage has skewed bearish: 0 bullish, 0 neutral, and 2 bearish.
Recent MTEX coverage spans corporate actions, earnings and regulation.
Earnings miss on revenue may trigger sell pressure.
Results miss revenue expectations and show deteriorating margins, offset by a large non‑cash tax benefit.
Regaining compliance removes a potential delisting risk and may improve investor confidence.
Potential delisting risk if Nasdaq does not accept the pro‑forma equity adjustment.
Board leadership change may affect governance and strategic direction.
AlphAI scores every news story that mentions MTEX with an AI model for sentiment and relevance, and aggregates insider trades from MANNATECH INC's SEC EDGAR Form 4 filings. Figures refresh continuously.
Mannatech reported Q3 GAAP earnings per share of $4.61 and revenue of $24.87M, down 14.8% year-over-year, according to a press release.
MANNATECH INC (MTEX) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Mannatech Reports Financial Results for Third Quarter 2026 (Flower Mound, Texas) November 12, 2026 - Mannatech, Incorporated (NASDAQ: MTEX ), ("Mannatech" or "Company"), global health and wellness company committed to transforming lives to make a better world, today
Mann (MTEX) believes it has regained compliance with Nasdaq's $2.5M equity requirement after acquiring 100% ownership of its Swiss subsidiary. The Swiss tax authority ruled distributions now qualify for a reduced 5% withholding rate, altering deferred tax liabilities. Nasdaq will continue monitoring. According to the company, the changes were effective as of September 30, 2026.
MANNATECH INC (MTEX) filed an SEC Form 8-K — Other Events. Item 8.01. Other Events. Nasdaq Deficiency. On April 20, 2026, Mannatech, Incorporated (the “Company”) received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it was not in compliance with the minimum stock
Mannatech (MTEX) announced Robert Toth as Chairman, replacing retiring Stanley Fredrick. Toth previously served on the board and as Vice Chairman. MTEX stock traded between $3.80 and $12.45 in the past year, closing at $7.15 on Tuesday. The company offers nutritional and wellness products.
MANNATECH INC (MTEX) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Exhibit 99.1 Mannatech Announces Retirement of J. Stanley Fredrick from the Board and Appointment of Robert Toth as Chairman of the Board FLOWER MOUND, Texas--(BUSINESS WIRE)—September 1, 2026-- Mannatech, Incorporated (NASDAQ: MTEX ) announced the retirement of J. Stanley Fredri
MANNATECH INC (MTEX) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Mannatech Reports Financial Results for Second Quarter 2026 (Flower Mound, Texas) August 12, 2026 - Mannatech, Incorporated (NASDAQ: MTEX ), ("Mannatech" or "Company"), global health and wellness company committed to transforming lives to make a better world, today a
MANNATECH INC (MTEX) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. mtex20260605_8k.htm false 0001056358 0001056358 2026-06-03 2026-06-03 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event repo
Mannatech (NASDAQ: MTEX) reported a net income of $2.3 million for Q4 2024, a significant improvement from a net loss in Q4 2023, despite an 11.3% decrease in net sales to $29.0 million. The company attributed this return to profitability to strict cost management, including substantial reductions in selling and administrative expenses. For the full year 2024, Mannatech also achieved a net income of $2.5 million, compared to a loss in 2023, by mitigating the impact of declining sales and challenging economic conditions, particularly in the Asia/Pacific region.